Department of Urology, Grenoble University Hospital, Grenoble, France.
UJF-Grenoble 1, CNRS, INSERM, TIMC-IMAG UMR 5525, 38041 Grenoble, France.
Int Braz J Urol. 2018 Jan-Feb;44(1):53-62. doi: 10.1590/S1677-5538.IBJU.2017.0311.
Super-selective clamping of tumor-specific segmental arteries was developed to eliminate ischemia of the remnant kidney while limiting hemorrhage during partial nephrectomy. The objective is to evaluate the benefice of super-selective clamping on renal functional outcome, compared to early-unclamping of the renal artery.
From March 2015 to July 2016, data from 30 patients undergoing super-selective robot-assisted PN (RAPN) for a solitary tumor by a single surgeon were prospectively collected. Tumor devascularization was assessed using indocyanine green near-infrared fluorescence. A matched-pair analysis with a retrospective cohort undergoing early-unclamping was conducted, adjusting on tumor complexity and preoperative eGFR. Perioperative, oncologic and functional outcomes using DMSA-renal scintigraphy were assessed. Multivariate analysis was performed to identify predictors of postoperative renal function and de novo chronic kidney disease (CKD).
Super-selective RAPN was successful in 23/30 patients (76.7%), 5 requiring secondary main artery clamping due to persistent tumor fluorescence. Matched-pair analysis showed similar operating time, blood loss, positives margins and complication rates. Super-selective clamping was associated with an improved eGFR variation at discharge (p=0.002), 1-month (p=0.01) and 6-month post-op (-2%vs-16% p=0.001). It also led to a better relative function on scintigraphy (46%vs40% p=0.04) and homolateral eGFR (p=0.04), and fewer upstaging to CKD stage ≥3 (p=0.03). On multivariate analysis, super-selective clamping was a predictor of postoperative renal function.
Super-selective RAPN leads to an improved preservation of renal function and a reduced risk of de novo CKD stage≥3, while keeping the benefit of main artery clamping on perioperative outcomes.
超选择性夹闭肿瘤特异性节段性动脉被开发出来,以消除部分肾切除术中残余肾脏的缺血,同时限制出血。目的是评估与早期肾动脉松解相比,超选择性夹闭对肾功能结果的益处。
从 2015 年 3 月到 2016 年 7 月,前瞻性收集了由一名外科医生对 30 例孤立肿瘤进行超选择性机器人辅助部分肾切除术(RAPN)的患者数据。使用吲哚菁绿近红外荧光评估肿瘤去血管化。对行早期松解的回顾性队列进行了配对分析,并调整了肿瘤复杂性和术前 eGFR。使用 DMSA-肾闪烁扫描评估围手术期、肿瘤学和功能结果。进行多变量分析以确定术后肾功能和新发慢性肾脏病(CKD)的预测因素。
23/30 例(76.7%)患者成功进行了超选择性 RAPN,5 例由于持续的肿瘤荧光而需要二次主动脉夹闭。配对分析显示手术时间、出血量、阳性切缘和并发症发生率相似。超选择性夹闭与出院时 eGFR 变化(p=0.002)、1 个月(p=0.01)和 6 个月(-2%对-16%,p=0.001)时 eGFR 改善相关。它还导致闪烁扫描的相对功能更好(46%对 40%,p=0.04)和同侧 eGFR 更好(p=0.04),新发 CKD 分期≥3 的风险降低(p=0.03)。多变量分析显示,超选择性夹闭是术后肾功能的预测因素。
超选择性 RAPN 可改善肾功能的保护,并降低新发 CKD 分期≥3 的风险,同时保持主动脉夹闭对围手术期结果的益处。